经导管三尖瓣介入治疗后可选择的起搏策略:程序挑战和经验教训。

IF 5.7 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Emily Tat, Tamim Nazif, Isaac George, Robin Le Ruz, Rebecca T Hahn, Angelo Biviano, Elaine Y Wan, Susheel K Kodali, Hirad Yarmohammadi, Deepak Saluja
{"title":"经导管三尖瓣介入治疗后可选择的起搏策略:程序挑战和经验教训。","authors":"Emily Tat, Tamim Nazif, Isaac George, Robin Le Ruz, Rebecca T Hahn, Angelo Biviano, Elaine Y Wan, Susheel K Kodali, Hirad Yarmohammadi, Deepak Saluja","doi":"10.1016/j.hrthm.2025.10.013","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Decision making regarding new pacemaker implantation following transcatheter tricuspid valve intervention (TTVI), including transcatheter edge-to-edge repair (TEER) or transcatheter tricuspid valve replacement (TTVR), is complex due to anatomic and TTVI-related challenges.</p><p><strong>Objective: </strong>To evaluate the feasibility of non-transvalvular pacing strategies including coronary sinus (CS) or leadless pacemaker (LP) placement, following TTVI.</p><p><strong>Methods: </strong>Consecutive patients undergoing TTVI at a single institution were retrospectively studied for new pacemaker indications and pacing strategy. Procedural challenges and outcomes associated with non-transvalvular pacemaker implantation were assessed.</p><p><strong>Results: </strong>Among 137 patients who underwent TTVI (69 TTVR, 68 TEER) at a single center, 34 (25%) patients were excluded for pre-existing pacemaker, and 15/103 (15%) patients subsequently developed an indication for pacing following TEER (n=5/53, 9%) or TTVR (n = 10/50, 20%). An alternative pacing strategy was attempted after TEER and TTVR. After TEER (n=5), CS lead placement was 50% successful (2/4) and one LP attempt was unsuccessful (0/1). After TTVR (n=10), CS lead placement was 75% successful (6/8) and LP placement was 100% successful (2/2) on initial attempt. CS lead placement was limited by CS anatomy, whereas LP placement was limited by TTVR interaction. A transvenous pacemaker was successfully placed if needed. No pacemaker device-related adverse event occurred in any patient peri-procedurally or at one year follow-up.</p><p><strong>Conclusion: </strong>Alternative non-transvalvular pacing strategies may be feasible and safe in patients who require pacing following TTVI. Pre-procedural planning with a multidisciplinary approach can help optimize procedural success. Further studies and longer-term follow-up are warranted.</p>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned.\",\"authors\":\"Emily Tat, Tamim Nazif, Isaac George, Robin Le Ruz, Rebecca T Hahn, Angelo Biviano, Elaine Y Wan, Susheel K Kodali, Hirad Yarmohammadi, Deepak Saluja\",\"doi\":\"10.1016/j.hrthm.2025.10.013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Decision making regarding new pacemaker implantation following transcatheter tricuspid valve intervention (TTVI), including transcatheter edge-to-edge repair (TEER) or transcatheter tricuspid valve replacement (TTVR), is complex due to anatomic and TTVI-related challenges.</p><p><strong>Objective: </strong>To evaluate the feasibility of non-transvalvular pacing strategies including coronary sinus (CS) or leadless pacemaker (LP) placement, following TTVI.</p><p><strong>Methods: </strong>Consecutive patients undergoing TTVI at a single institution were retrospectively studied for new pacemaker indications and pacing strategy. Procedural challenges and outcomes associated with non-transvalvular pacemaker implantation were assessed.</p><p><strong>Results: </strong>Among 137 patients who underwent TTVI (69 TTVR, 68 TEER) at a single center, 34 (25%) patients were excluded for pre-existing pacemaker, and 15/103 (15%) patients subsequently developed an indication for pacing following TEER (n=5/53, 9%) or TTVR (n = 10/50, 20%). An alternative pacing strategy was attempted after TEER and TTVR. After TEER (n=5), CS lead placement was 50% successful (2/4) and one LP attempt was unsuccessful (0/1). After TTVR (n=10), CS lead placement was 75% successful (6/8) and LP placement was 100% successful (2/2) on initial attempt. CS lead placement was limited by CS anatomy, whereas LP placement was limited by TTVR interaction. A transvenous pacemaker was successfully placed if needed. No pacemaker device-related adverse event occurred in any patient peri-procedurally or at one year follow-up.</p><p><strong>Conclusion: </strong>Alternative non-transvalvular pacing strategies may be feasible and safe in patients who require pacing following TTVI. Pre-procedural planning with a multidisciplinary approach can help optimize procedural success. Further studies and longer-term follow-up are warranted.</p>\",\"PeriodicalId\":12886,\"journal\":{\"name\":\"Heart rhythm\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2025-10-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heart rhythm\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.hrthm.2025.10.013\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart rhythm","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.hrthm.2025.10.013","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:经导管三尖瓣介入(TTVI)后的新起搏器植入决策,包括经导管边缘到边缘修复(TEER)或经导管三尖瓣置换术(TTVR),由于解剖学和TTVI相关的挑战,是复杂的。目的:评价TTVI后非经瓣膜起搏策略的可行性,包括冠状动脉窦(CS)或无导联起搏器(LP)放置。方法:回顾性研究在单一机构连续接受TTVI的患者新的起搏器适应症和起搏策略。评估了非经瓣膜起搏器植入的程序挑战和结果。结果:在单中心接受TTVI治疗的137例患者(69例TTVR, 68例TEER)中,34例(25%)患者因已有起搏器而被排除,15/103例(15%)患者在接受TEER治疗(n=5/ 53,9%)或TTVR治疗(n= 10/ 50,20%)后出现起搏指征。在TEER和TTVR后尝试另一种起搏策略。TEER (n=5)后,CS引线放置成功率为50% (2/4),LP放置失败1次(0/1)。在TTVR (n=10)后,初次尝试时,CS引线放置成功率为75% (6/8),LP放置成功率为100%(2/2)。CS导联放置受CS解剖结构限制,而LP放置受TTVR相互作用限制。如果需要,经静脉起搏器被成功放置。在围手术期或一年随访期间,没有任何患者发生与起搏器相关的不良事件。结论:对于TTVI后需要起搏的患者,其他非经瓣膜起搏策略可能是可行和安全的。术前规划与多学科的方法可以帮助优化手术的成功。进一步的研究和长期随访是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Alternative Pacing Strategies Following Transcatheter Tricuspid Valve Interventions: Procedural Challenges and Lessons Learned.

Background: Decision making regarding new pacemaker implantation following transcatheter tricuspid valve intervention (TTVI), including transcatheter edge-to-edge repair (TEER) or transcatheter tricuspid valve replacement (TTVR), is complex due to anatomic and TTVI-related challenges.

Objective: To evaluate the feasibility of non-transvalvular pacing strategies including coronary sinus (CS) or leadless pacemaker (LP) placement, following TTVI.

Methods: Consecutive patients undergoing TTVI at a single institution were retrospectively studied for new pacemaker indications and pacing strategy. Procedural challenges and outcomes associated with non-transvalvular pacemaker implantation were assessed.

Results: Among 137 patients who underwent TTVI (69 TTVR, 68 TEER) at a single center, 34 (25%) patients were excluded for pre-existing pacemaker, and 15/103 (15%) patients subsequently developed an indication for pacing following TEER (n=5/53, 9%) or TTVR (n = 10/50, 20%). An alternative pacing strategy was attempted after TEER and TTVR. After TEER (n=5), CS lead placement was 50% successful (2/4) and one LP attempt was unsuccessful (0/1). After TTVR (n=10), CS lead placement was 75% successful (6/8) and LP placement was 100% successful (2/2) on initial attempt. CS lead placement was limited by CS anatomy, whereas LP placement was limited by TTVR interaction. A transvenous pacemaker was successfully placed if needed. No pacemaker device-related adverse event occurred in any patient peri-procedurally or at one year follow-up.

Conclusion: Alternative non-transvalvular pacing strategies may be feasible and safe in patients who require pacing following TTVI. Pre-procedural planning with a multidisciplinary approach can help optimize procedural success. Further studies and longer-term follow-up are warranted.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Heart rhythm
Heart rhythm 医学-心血管系统
CiteScore
10.50
自引率
5.50%
发文量
1465
审稿时长
24 days
期刊介绍: HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability. HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community. The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信